CAS: 189261-10-7 - Immunoglobulin G4, anti-(human integrin α4) (human-mouse monoclonal AN100226 γ4-chain), disulfide with human-mouse monoclonal AN100226 light chain, dimer
| Marca | Datos del producto | Pureza | Rango de precios | Entrega estimada |
|---|---|---|---|---|
 | Natalizumab REF: TM-T12177CAS: 189261-10-7 | 98.00% | 163,00 €~926,00 € | Vie 17 May 24 |
 | Natalizumab REF: 3D-FN139133CAS: 189261-10-7 | Min. 95% | A consultar | Vie 21 Jun 24 |
Natalizumab
CAS:189261-10-7
Natalizumab used for the treatment of relapsing remitting multiple sclerosis and Crohn's disease.
Pureza:
98.00%
Forma y color:
Solid
Peso molecular:
N/A
Ref: TM-T12177
| 1mg | 163,00 € | |
| 2mg | 233,00 € | |
| 5mg | 396,00 € | |
| 10mg | 637,00 € | |
| 25mg | 926,00 € |
Entrega estimada en Estados Unidos, el Viernes 17 de Mayo de 2024
Natalizumab
CAS:189261-10-7
Monoclonal antibody against α4-integrin
Fórmula:
C40H55N7O11S
Pureza:
Min. 95%
Peso molecular:
841.97
Ref: 3D-FN139133
| 1mg | A consultar |
Entrega estimada en Estados Unidos, el Viernes 21 de Junio de 2024
